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Introduction:	   Membranous	   glomerulonephritis	   is	   commonly	   described	   in	   systemic	   lupus	   erythematosus	   (SLE)	   and	  
hypothyroidism.	   	  
	  
Clinical	  presentation:	  We	  report	  a	  case	  of	  a	  40-­‐year-­‐old	  woman	  who	  presented	  with	  a	  membranous	  glomerulonephritis	  
associated	  with	  SLE,	  rheumatoid	  arthritis	  and	  hypothyroidism	  due	  to	  Hashimoto’s	  thyroiditis.	  
	  
Conclusions:	   The	   simultaneous	   occurrence	   of	   these	   three	   diseases	   as	   possible	   causes	   of	   membranous	  
glomerulonephritis	  is	  extremely	  exceptional.	  
	   	  





Membranous	  glomerulonephritis,	  described	  as	  Class	  V	  of	  lupus	  nephritis,	  is	  rarely	  observed	  in	  rheumatoid	  arthritis	  (RA)	  
and	  Hashimoto’s	  thyroiditis	  [1–3].	   	  
We	   report	   an	   interesting	   case	  of	   concomitant	   systemic	   lupus	   erythematosus	   (SLE),	   RA,	  Hashimoto’s	   thyroiditis	   and	   a	  
membranous	  glomerulonephritis.	  
	  
Case	  report	   	  
A	  40-­‐year-­‐old	  woman	  with	  no	  medical	  past	  history	  was	  referred	  for	   limb	  oedema	  and	   inflammatory	  arthralgia	  for	  the	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metcarpo-­‐phalangeal	   joints	  and	  thyroid	  goitre.	  Her	  blood	  pressure	  was	  120/80	  mmHg.	  Biological	  examination	  showed	  
normocytic	   anaemia	   (haemoglobinaemia=9.1	   g/l),	   lymphopenia	   (lymphocyte	   count	   1300/mm3),	   hypoprotidaemia	   (28	  
g/l),	   hypoalbuminaemia	   (9.4	   g/dl)	   with	   serum	   creatinine	   at	   89	   μmol/l	   (creatinine	   clearance	   60	   ml/min),	  
hypercholesterolaemia	   (13.3	  mmol/l)	   and	   hypertriglyceridaemia	   (9.6	  mmol/l).	   Urinary	   examination	   revealed	  massive	  
proteinuria	  (8.85	  g/24	  h),	  leucocyturia	  (400/mm3)	  and	  haematuria	  (69/mm3).	  TSH	  level	  was	  elevated	  at	  16.3	  mUI/l	  (0.2–
5)	  and	  FT4	  was	   low	  at	  5	  pmol/l	   (6–23).	   Serological	   tests	  of	  viral	  hepatitis	  B	  and	  C,	  HIV,	  EBV	  and	  CMV	  were	  negative.	  
Complement	  was	  consumed	  (C3,	  0.73	  g/l;	  C4,	  0.14	  g/l).	  Antinuclear	  antibodies	  (ANA)	  and	  DNA	  antibodies	  were	  positive	  
(ANA=1/320	  controlled	  1/1200	  homogeneous	  speckled;	  DNA	  antibodies:	   IFA	  Crithidia	   lucilae	  +++,	  ELISA	  +++;	  ENT:	  anti	  
Sm+,	  antinucleosome	  +).	  Rheumatoid	  factors	  (RF,	  187	  UA/ml	  (N<30)	  and	  anticyclic	  citrullinated	  peptide	  antibodies	  were	  
positive	  (anti	  CCP,	  98	  U/ml	  (N<25)).	  Anti-­‐thyroglobulin	  antibodies	  were	  positive	  at	  high	  titre	  (980	  UI/ml;	  normal	  ≤	  100).	  
Cervical	  ultrasound	  revealed	  a	  multinodular	  goitre.	  A	  diagnosis	  of	  Hashimoto’s	  thyroiditis	  was	  then	  made.	  X-­‐rays	  of	  the	  
wrists	   showed	  severe	  carpitis.	  The	  diagnosis	  of	  SLE	  was	   retained	  considering	   four	  ACR	  criteria:	   lymphopenia,	  positive	  
ANA,	  positive	  anti-­‐DNA	  and	  proteinuria.	  A	  diagnosis	  of	  RA	  was	  made	  based	  on	  distal	  joint	  synovitis,	  radiological	  carpitis	  
and	  positive	   immunological	   tests.	  A	  percutaneous	   renal	  biopsy	  was	  performed	  and	   the	  histopathological	  examination	  
showed	  a	  membranous	  glomerulonephritis	  with	  focal	  mesangial	  proliferation	  and	  segmental	  hyalinosis	  (Figs.	  1	  and	  2).	  
Immunoglobulin	   type	   G	   and	   M,	   complement	   (C3,	   C1q)	   and	   fibrinogen	   deposits	   were	   detected	   on	   standard	   direct	  
immunofluorescence.	  
	  
The	  patient	  was	   treated	  with	   intravenous	  boli	  of	  methylprednisolone	   relayed	  with	  oral	   corticosteroids	  at	  a	  dose	  of	  1	  
mg/kg/day.	  Immunosuppressive	  treatment	  with	  six	  bimensual	  boli	  of	  cyclophosphamide	  relayed	  with	  azathioprine	  was	  
also	  performed.	  She	  was	  also	  treated	  with	  thyroid	  hormones.	  The	  outcome	  was	  favourable,	  marked	  by	  an	  improvement	  




Figure	  1:	  Photo	  of	  the	  histopathological	  examination	  of	  kidney	  biopsy	  
(Trichrome	  Masson,	  magnification	  400×):	  membranous	  
glomerulonephritis	  with	  focal	  mesangial	  proliferation.	  
Figure	  2:	  Photo	  of	  histopathological	  examination	  of	  kidney	  biopsy	  
(silver	  staining):	  membranous	  glomerulonephritis	  and	  spikes.	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Discussion	  
Membranous	   glomerulonephritis	   is	   a	   pattern	   of	   injury	   that	   results	   from	   subendothelial	   and	  mesangial	   deposition	   of	  
immunoglobulins	  caused	  by	  persistent	  antigenaemia	  and/or	  circulating	  immune	  complexes	  [4].	  It	  is	  typically	  classified	  as	  
idiopathic	  or	  secondary	  to	  infections,	  drugs,	  toxins,	  malignancy	  or	  autoimmune	  disease	  especially	  to	  SLE.	   	   	  
In	  this	  case,	  we	  analyze	  the	  occurrence	  of	  membranous	  glomerulonephritis	  in	  a	  patient	  with	  three	  autoimmune	  diseases.	  
Autoimmune	  disorders	  can	  be	  organ-­‐specific	  or	  they	  can	  involve	  multiple	  organs.	  The	  common	  characteristic	  of	  all	  these	  
disorders	  is	  the	  production	  of	  different	  autoantibodies	  against	  various	  autoantigens	  along	  with	  inflammation.	   	  
Membranous	  glomerulonephritis	  represents	  about	  20%	  of	  clinically	  significant	  renal	  disease	  in	  SLE	  [1].	  Few	  studies	  have	  
directly	   addressed	   the	   pathogenesis	   of	   membranous	   glomerulonephritis.	   Natural	   history	   studies	   of	   membranous	  
glomerulonephritis	   in	   SLE	   suggest	   a	   relatively	   low	   rate	   of	   progression	   to	   end-­‐stage	   renal	   disease	   but	   a	   high	   rate	   of	  
significant	   comorbidities	   [5].	   Considering	   the	   nephrotic	   syndrome,	   the	   patient	   was	   treated	  with	   immunosuppressive	  
therapies,	  including	  corticosteroids	  and	  cyclophosphamide.	   	  
Renal	   involvement	   during	   RA	   is	   rare	   [6].	   Renal	   lesions	   directly	   due	   to	   the	   disease	   itself	   are	   infrequent.	   Regarding	  
membranous	  glomerulonephritis,	  the	  relationship	  between	  with	  RA	  remains	  unclear.	  Membranous	  glomerulonephritis	  
is	   generally	   accepted	   as	   the	  most	   frequent	   histological	   lesion	   during	   treatment	   with	   gold	   salts,	   D-­‐penicillamine	   and	  
bucillamine,	   although	   other	   authors	   have	   described	   a	   direct	   relationship	   with	   RA	   [2,	   7].	   Membranous	  
glomerulonephritis	  had	  occurred	  in	  our	  patient	  before	  beginning	  treatment.	  So,	  it	  may	  be	  directly	  related	  to	  RA.	  In	  fact,	  
even	  if	  the	  pathogenesis	  of	  membranous	  glomerulonephritis	  in	  RA	  is	  still	  unknown,	  it	  is	  hypothesized	  that	  the	  presence	  
of	  circulating	   immune	  complexes	  and	  rheumatoid	  factor,	  or	  alteration	   in	  T	  cell	   immune	  response	  and	  the	  presence	  of	  
proinflammatory	  cytokines,	  may	  have	  played	  a	  role	  in	  the	  pathogenesis	  of	  the	  nephropathy.	  
Thyroid	   pathology	   has	   a	   high	   prevalence	   in	   the	   general	   population,	   although	   autoimmune	   aetiology	   is	   rare.	   It	   is	  
associated	   with	   a	   variety	   of	   glomerulonephritis	   types	   in	   very	   few	   cases,	   the	   most	   frequent	   being	   membranous	  
glomerulonephritis	  [8].	  As	  reported	  by	  some	  authors,	  simultaneous	  occurrence	  of	  thyroid	  and	  glomerular	  disease	  could	  
be	   explained	   by	   the	   existence	   of	   an	   autoimmune	   pathogenesis	   common	   to	   both	   conditions,	   and	   incidence	   could	   be	  
higher	  than	  suspected,	  with	  proteinuria	  being	  found	  in	  a	  high	  proportion	  of	  patients	  with	  autoimmune	  thyroiditis	  and	  
Graves’	  disease	  [8–10].	   In	  our	  case,	  thyroiditis	  was	  diagnosed	  based	  on	  positive	  antithyroid	  antibodies,	  and	   its	  clinical	  
manifestation	  was	  a	  clinical	  hypothyroidism.	  The	  parallelism	  seen	  between	  remission	  of	  nephrotic	  syndrome	  and	  TSH	  
normalization	  under	   treatment	  with	   thyroid	  hormone	  and	  corticosteroids	  should	  be	  noted.	  So,	   in	  cases	  of	  apparently	  
idiopathic	  nephrotic	   syndrome,	   thyroid	   function	  needs	   to	  be	   investigated	   [9,	   10].	  Membranous	  glomerulonephritis	   in	  
this	  case	  is	  probably	  secondary	  to	  autoimmune	  disorders	  caused	  by	  the	  exceptional	  simultaneous	  occurrence	  of	  these	  




• Lupus	  is	  a	  classical	  aetiology	  of	  membranous	  glomerulonephritis.	  
• Membranous	  glomerulonephritis	  is	  an	  uncommon	  extra-­‐articular	  manifestation	  of	  rheumatoid	  arthritis.	   	  
• Autoimmune	  thyroiditis	  with	  nephrotic	  syndrome	  is	  marked	  by	  predominant	  membranous	  glomerulonephritis.	   	  
 	  
Doi:	  10.12890/2014_000122	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   European	  Journal	  of	  Case	  Reports	  in	  Internal	  Medicine	   	  
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   ©	  EFIM	  2014	  
• It	  is	  necessary	  to	  perform	  an	  analysis	  of	  the	  thyroid	  hormones	  in	  every	  patient	  with	  nephrotic	  syndrome	  as	  part	  
of	  an	  aetiological	  screening	  process.	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